Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity (Q39053372)
Jump to navigation
Jump to search
scientific article published on 12 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity |
scientific article published on 12 October 2013 |
Statements
1 reference
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity (English)
1 reference
Laura Quotti Tubi
1 reference
Carmela Gurrieri
1 reference
Alessandra Brancalion
1 reference
Laura Bonaldi
1 reference
Roberta Bertorelle
1 reference
Laura Pavan
1 reference
Federica Lessi
1 reference
Renato Zambello
1 reference
Fausto Adami
1 reference
12 October 2013
1 reference
1 reference
78
1 reference
Identifiers
1 reference
1 reference
1 reference
1 reference